These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6238196)

  • 1. [Experience with the treatment of patients with hypertrophic cardiomyopathy with obsidan and isoptin].
    Kisliak OA; Storozhakov GI
    Kardiologiia; 1984 Aug; 24(8):27-30. PubMed ID: 6238196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
    Lösse B; Kuhn H; Loogen F
    Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
    Lösse B; Loogen F; Schulte HD
    Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Echocardiographic parameters in hypertrophic cardiomyopathy during verapamil treatment (author's transl].
    Lemke R; Hopf R; Kober G; Kaltenbach M
    Z Kardiol; 1980 Oct; 69(10):661-8. PubMed ID: 7192909
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study.
    Kober G; Hopf R; Biamino G; Bubenheimer P; Förster K; Kuck KH; Hanrath P; von Olshausen KE; Schlepper M; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():113-8. PubMed ID: 3324526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of the degree of hypertrophy in hypertrophic obstructive cardiomyopathy under medical and surgical treatment.
    Curtius JM; Stoecker J; Loesse B; Welslau R; Scholz D
    Cardiology; 1989; 76(4):255-63. PubMed ID: 2529965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T; Hess OM; Jenni R; Krayenbühl HP
    Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Echocardiographic and hemodynamic studies on the influence of verapamil in hypertrophic obstructive cardiomyopathy (author's transl)].
    Schmid P; Pavek P; Klein W
    Z Kardiol; 1979 Feb; 68(2):89-92. PubMed ID: 570768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of current ultrasonic study methods for the diagnosis, follow-up of treatment effectiveness and prognosis of patients with hypertrophic obstructive cardiomyopathy].
    Pal L; Fedorova IF; Schäfer R; Sergakova LM; Naumov VG
    Ter Arkh; 1987; 59(10):90-4. PubMed ID: 3433228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial biopsy in patients with hypertrophic cardiomyopathy: correlations between morphologic and clinical parameters and development of myocardial hypertrophy under medical therapy.
    Kunkel B; Schneider M; Eisenmenger A; Bergmann B; Hopf R; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():33-8. PubMed ID: 2963449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical treatment of hypertrophic myocardiopathy. Comparison of propranolol and verapamil].
    Bouhour JB; Potiron M; Chiffoleau S; Lefévre M; Louvet S
    Arch Mal Coeur Vaiss; 1987 Jan; 80(1):76-82. PubMed ID: 3107495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hypertrophic cardiomyopathy with nifedipine and propranolol in combination].
    Hopf R; Thomas J; Klepzig H; Kaltenbach M
    Z Kardiol; 1987 Aug; 76(8):469-78. PubMed ID: 3673167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative evaluation of the effects of isoptin and obsidan on central and cerebral hemodynamics in patients with hypertension during physical exercise].
    Adibaev OA; Aleĭnikov VK; Veber VR; Kazymov MS
    Kardiologiia; 1990 Mar; 30(3):60-2. PubMed ID: 2199721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of verapamil on the indicators of left-ventricular diastole in hypertrophic cardiomyopathy].
    Dabrowski M; Górecka B; Witkowski A; Jodkowski J; Woroszylska M; Ruzyłło W
    Kardiol Pol; 1986; 29(5-6):345-55. PubMed ID: 3784250
    [No Abstract]   [Full Text] [Related]  

  • 17. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
    Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
    Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical and surgical treatment of hypertrophic cardiomyopathy.
    Goodwin JF; Oakley CM
    Eur Heart J; 1983 Nov; 4 Suppl F():209-14. PubMed ID: 6686537
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of isoptin and obsidan on the coronary blood flow and tactics in anti-angina therapy of patients with ischemic heart disease].
    Vakhliev VD; Bogatyrev IV; Uchaĭkina LV; Syrkin AL
    Kardiologiia; 1988 Oct; 28(10):36-9. PubMed ID: 3066966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy.
    Hopf R; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():105-12. PubMed ID: 3433863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.